Cumberland Pharmaceuticals's total assets for Q3 2024 were $76.75M, a decrease of -2.26% from the previous quarter. CPIX total liabilities were $52.28M for the fiscal quarter, a -0.40% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.